These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9643274

  • 1. Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).
    Stimpel M, Koch B, Oparil S.
    Cardiology; 1998 May; 89(4):271-6. PubMed ID: 9643274
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
    Chrysant SG, Stimpel M.
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):384-90. PubMed ID: 9514183
    [Abstract] [Full Text] [Related]

  • 3. Moexipril as add-on therapy to hydrochlorothiazide in moderate to severe hypertension.
    Stimpel M, Koch B, Dickstein K.
    Cardiology; 1996 Mar; 87(4):313-8. PubMed ID: 8793166
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients.
    Persson B, Stimpel M.
    Eur J Clin Pharmacol; 1996 Mar; 50(4):259-64. PubMed ID: 8803515
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension.
    White WB, Koch B, Stimpel M.
    Am J Ther; 1997 Apr; 4(4):123-9. PubMed ID: 10423601
    [Abstract] [Full Text] [Related]

  • 6. Comparison between moexipril and atenolol in obese postmenopausal women with hypertension.
    Stimpel M, Koch B, Weber MA.
    Maturitas; 1998 Sep 20; 30(1):69-77. PubMed ID: 9819786
    [Abstract] [Full Text] [Related]

  • 7. Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women.
    Koch B, Oparil S, Stimpel M.
    J Hum Hypertens; 1999 May 20; 13(5):337-42. PubMed ID: 10376852
    [Abstract] [Full Text] [Related]

  • 8. Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized rats.
    Ma YF, Stimpel M, Liang H, Pun S, Jee WS.
    J Endocrinol; 1997 Sep 20; 154(3):467-74. PubMed ID: 9379124
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive treatment with moexipril plus HCTZ vs metoprolol plus HCTZ in patients with mild-to-moderate hypertension.
    Stimpel M, Koch B.
    J Hum Hypertens; 1997 Feb 20; 11(2):133-7. PubMed ID: 9140801
    [Abstract] [Full Text] [Related]

  • 10. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
    Chrysant SG, Fox AA, Stimpel M.
    Am J Hypertens; 1995 Apr 20; 8(4 Pt 1):418-21. PubMed ID: 7619356
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. MADAM study group. Moexipril as Antihypertensive Drug After Menopause.
    Agabiti-Rosei E, Ambrosioni E, Pirelli A, Stimpel M, Zanchetti A.
    Eur J Clin Pharmacol; 1999 May 20; 55(3):185-9. PubMed ID: 10379633
    [Abstract] [Full Text] [Related]

  • 12. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Romero R, Castellote E, Ocón J, Wagner B.
    J Cardiovasc Pharmacol; 1995 Jul 20; 26(1):114-8. PubMed ID: 7564350
    [Abstract] [Full Text] [Related]

  • 13. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
    White WB, Stimpel M.
    J Hum Hypertens; 1995 Nov 20; 9(11):879-84. PubMed ID: 8583466
    [Abstract] [Full Text] [Related]

  • 14. Moexipril versus captopril in patients with mild to moderate hypertension.
    Stimpel M, Koch B, Jansen T, Fox A, Loh I.
    J Cardiovasc Pharmacol; 1996 Dec 20; 28(6):769-73. PubMed ID: 8961074
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the antihypertensive effectiveness of a combination of moexipril or sustained-release verapamil with low-dose hydrochlorothiazide.
    Chrysant SG, Stimpel M.
    J Clin Pharmacol; 1996 Aug 20; 36(8):701-6. PubMed ID: 8877673
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.
    Malmqvist K, Kahan T, Dahl M.
    Am J Hypertens; 2000 May 20; 13(5 Pt 1):504-11. PubMed ID: 10826401
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacy of three dose levels of moexipril versus placebo as add-on therapy to hydrochlorothiazide in patients with moderate hypertension.
    Dickstein K, Aarsland T, Ferrari P, Todd M, Stimpel M.
    J Cardiovasc Pharmacol; 1994 Aug 20; 24(2):247-55. PubMed ID: 7526056
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy and safety of moexipril in the treatment of hypertension.
    White WB, Fox AA, Stimpel M.
    J Hum Hypertens; 1994 Dec 20; 8(12):917-21. PubMed ID: 7884791
    [Abstract] [Full Text] [Related]

  • 19. Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group.
    Weir MR, Reisin E, Falkner B, Hutchinson HG, Sha L, Tuck ML.
    Am J Hypertens; 1998 Aug 20; 11(8 Pt 1):914-20. PubMed ID: 9715782
    [Abstract] [Full Text] [Related]

  • 20. Moexipril. A review of its use in the management of essential hypertension.
    Brogden RN, Wiseman LR.
    Drugs; 1998 Jun 20; 55(6):845-60. PubMed ID: 9617599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.